Francesca Aweeka

7.9k total citations
143 papers, 5.4k citations indexed

About

Francesca Aweeka is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Virology. According to data from OpenAlex, Francesca Aweeka has authored 143 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Infectious Diseases, 48 papers in Public Health, Environmental and Occupational Health and 47 papers in Virology. Recurrent topics in Francesca Aweeka's work include HIV/AIDS drug development and treatment (74 papers), HIV Research and Treatment (47 papers) and Malaria Research and Control (40 papers). Francesca Aweeka is often cited by papers focused on HIV/AIDS drug development and treatment (74 papers), HIV Research and Treatment (47 papers) and Malaria Research and Control (40 papers). Francesca Aweeka collaborates with scholars based in United States, Uganda and Thailand. Francesca Aweeka's co-authors include Terrence F. Blaschke, Monica Gandhi, Ruth M. Greenblatt, Anura L. Jayewardene, Liusheng Huang, John G. Gambertoglio, Patricia Lizak, Polina German, Kathleen Mulligan and Morris Schambelan and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Francesca Aweeka

140 papers receiving 5.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Francesca Aweeka United States	40	2.7k	1.6k	1.1k	1.1k	865	143	5.4k
Edmund V. Capparelli United States	49	3.5k 1.3×	1.6k 1.0×	1.3k 1.1×	908 0.8×	1.5k 1.7×	270	8.3k
Catia Marzolini Switzerland	36	3.5k 1.3×	1.9k 1.2×	391 0.4×	891 0.8×	950 1.1×	130	6.0k
Jean‐Marc Tréluyer France	44	1.8k 0.7×	713 0.4×	1.1k 1.0×	525 0.5×	1.2k 1.4×	326	7.3k
Stephen C. Piscitelli United States	52	4.4k 1.6×	2.1k 1.3×	344 0.3×	564 0.5×	2.1k 2.4×	169	7.9k
Edward P. Acosta United States	49	5.7k 2.1×	4.0k 2.5×	512 0.5×	1.1k 1.0×	1.6k 1.8×	214	8.1k
Richard M. W. Hoetelmans Netherlands	42	4.2k 1.6×	3.1k 1.9×	262 0.2×	768 0.7×	949 1.1×	139	5.2k
Marta Boffito United Kingdom	37	3.4k 1.3×	2.0k 1.2×	254 0.2×	1.1k 1.0×	1.0k 1.2×	253	4.6k
Brookie M. Best United States	37	1.9k 0.7×	807 0.5×	1.1k 1.0×	698 0.6×	532 0.6×	129	4.2k
Stefano Bonora Italy	34	2.5k 0.9×	1.3k 0.8×	207 0.2×	795 0.7×	962 1.1×	223	3.8k
Antonio D’Avolio Italy	36	2.5k 0.9×	857 0.5×	231 0.2×	354 0.3×	1.2k 1.4×	323	5.4k

Countries citing papers authored by Francesca Aweeka

Since Specialization

Citations

This map shows the geographic impact of Francesca Aweeka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Aweeka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Aweeka more than expected).

Fields of papers citing papers by Francesca Aweeka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Aweeka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Aweeka. The network helps show where Francesca Aweeka may publish in the future.

Co-authorship network of co-authors of Francesca Aweeka

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Aweeka. A scholar is included among the top collaborators of Francesca Aweeka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Aweeka. Francesca Aweeka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kajubi, Richard, Justin Goodwin, Liusheng Huang, et al.. (2025). Extended Treatment Duration of Artemether‐Lumefantrine in Ugandan Children with HIV on Efavirenz‐Based Antiretroviral Therapy: A Randomized Controlled Pharmacokinetic and Pharmacodynamic Trial. The Journal of Clinical Pharmacology. 65(7). 909–922.

Mwebaza, Norah, Michelle E. Roh, Yi Geng, et al.. (2024). Drug–Drug Interaction Between Dihydroartemisinin–Piperaquine and Sulfadoxine‐Pyrimethamine During Malaria Chemoprevention in Pregnant Women. Clinical Pharmacology & Therapeutics. 117(2). 506–514. 2 indexed citations

Roh, Michelle E., Issaka Zongo, Alassane Haro, et al.. (2023). Seasonal Malaria Chemoprevention Drug Levels and Drug Resistance Markers in Children With or Without Malaria in Burkina Faso: A Case-Control Study. The Journal of Infectious Diseases. 228(7). 926–935. 8 indexed citations

Wallender, Erika, Ali M. Ali, Emma Hughes, et al.. (2021). Identifying an optimal dihydroartemisinin-piperaquine dosing regimen for malaria prevention in young Ugandan children. Nature Communications. 12(1). 6714–6714. 11 indexed citations

Hughes, Emma, Erika Wallender, Richard Kajubi, et al.. (2021). Piperaquine-Induced QTc Prolongation Decreases With Repeated Monthly Dihydroartemisinin-Piperaquine Dosing in Pregnant Ugandan Women. Clinical Infectious Diseases. 75(3). 406–415. 9 indexed citations

Prahl, Mary, Pamela M. Odorizzi, David Gingrich, et al.. (2021). Exposure to pesticides in utero impacts the fetal immune system and response to vaccination in infancy. Nature Communications. 12(1). 25 indexed citations

Haas, David W., Yoninah Cramer, Catherine Godfrey, et al.. (2020). Pharmacogenetic interactions between antiretroviral drugs and vaginally administered hormonal contraceptives. Pharmacogenetics and Genomics. 30(3). 45–53. 8 indexed citations

Huang, Liusheng, Janus A. J. Haagensen, Davide Verotta, et al.. (2018). Determination of Tobramycin in M₉ Medium by LC-MS/MS: Signal Enhancement by Trichloroacetic Acid. Journal of Analytical Methods in Chemistry. 2018. 1–8. 8 indexed citations

Wallender, Erika, Nan Zhang, Melissa D. Conrad, et al.. (2018). Modeling Prevention of Malaria and Selection of Drug Resistance with Different Dosing Schedules of Dihydroartemisinin-Piperaquine Preventive Therapy during Pregnancy in Uganda. Antimicrobial Agents and Chemotherapy. 63(2). 13 indexed citations

10.

Ali, Ali M., Melissa A. Penny, Thomas A. Smith, et al.. (2018). Population Pharmacokinetics of the Antimalarial Amodiaquine: a Pooled Analysis To Optimize Dosing. Antimicrobial Agents and Chemotherapy. 62(10). 23 indexed citations

11.

Ivaturi, Vijay, Christopher C. Dvorak, Tao Liu, et al.. (2017). Pharmacokinetics and Model-Based Dosing to Optimize Fludarabine Therapy in Pediatric Hematopoietic Cell Transplant Recipients. Biology of Blood and Marrow Transplantation. 23(10). 1701–1713. 40 indexed citations

12.

Dumond, Julie B., Joseph Rigdon, Katie R. Mollan, et al.. (2015). Brief Report. JAIDS Journal of Acquired Immune Deficiency Syndromes. 70(5). 510–514. 5 indexed citations

13.

Scarsi, Kimberly K., Fatai A. Fehintola, Qing Ma, et al.. (2014). Disposition of amodiaquine and desethylamodiaquine in HIV-infected Nigerian subjects on nevirapine-containing antiretroviral therapy. Journal of Antimicrobial Chemotherapy. 69(5). 1370–1376. 15 indexed citations

14.

Creek, Darren J., Victor Bigira, Emmanuel Arinaitwe, et al.. (2013). Pharmacokinetic Predictors for Recurrent Malaria After Dihydroartemisinin-Piperaquine Treatment of Uncomplicated Malaria in Ugandan Infants. The Journal of Infectious Diseases. 207(11). 1646–1654. 19 indexed citations

15.

Sha, Beverly E., Camlin Tierney, Susan E. Cohn, et al.. (2011). Postpartum Viral Load Rebound in HIV-1–Infected Women Treated with Highly Active Antiretroviral Therapy: AIDS Clinical Trials Group Protocol A5150. HIV Clinical Trials. 12(1). 9–23. 31 indexed citations

16.

Favre, David, Jeff E. Mold, Peter W. Hunt, et al.. (2010). Tryptophan Catabolism by Indoleamine 2,3-Dioxygenase 1 Alters the Balance of T _H 17 to Regulatory T Cells in HIV Disease. Science Translational Medicine. 2(32). 32ra36–32ra36. 423 indexed citations

17.

Vogler, Mary, Kristine B. Patterson, Lori Kamemoto, et al.. (2010). Contraceptive Efficacy of Oral and Transdermal Hormones When Co-Administered With Protease Inhibitors in HIV-1-Infected Women: Pharmacokinetic Results of ACTG Trial A5188. JAIDS Journal of Acquired Immune Deficiency Syndromes. 55(4). 473–482. 42 indexed citations

18.

Yilmaz, Aylin, Magnus Gisslén, Serena Spudich, et al.. (2009). Raltegravir Cerebrospinal Fluid Concentrations in HIV-1 Infection. PLoS ONE. 4(9). e6877–e6877. 66 indexed citations

19.

Chi, Jingduan, Anura L. Jayewardene, Judith Stone, & Francesca Aweeka. (2003). An LC-MS-MS method for the determination of nevirapine, a non-nucleoside reverse transcriptase inhibitor, in human plasma. Journal of Pharmaceutical and Biomedical Analysis. 31(5). 953–959. 28 indexed citations

20.

Kosel, Bradley W., Francesca Aweeka, Neal L. Benowitz, et al.. (2002). The effects of cannabinoids on the pharmacokinetics of indinavir and nelfinavir. AIDS. 16(4). 543–550. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact